D. D. Ankola - Concepedia

Author

D. D. Ankola

University of Strathclyde

Also Known As

Ankola, Dhawal Dhirajlal, D D Ankola, D. D. Ankola, D.D. Ankola, Dhawal D. Ankola

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Strathclyde National Institute of Pharmaceutical Education and Research National Institute of Pharmaceutical Education and Research University of Pisa

About

D. D. Ankola is an author at University of Strathclyde specializing in engineering, nanomedicine, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	7	7	1.2K
2	Medicine	7	7	1.3K
3	Biomedical Engineering	4	4	1.1K
4	Chemistry	2	2	30
5	Biomolecular Engineering	1	1	17

D. D. Ankola

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Jamaluddin Shaikh, D. D. Ankola, Vikas Beniwal, European Journal of Pharmaceutical Sciences NanomedicineOral BioavailabilityEngineeringPharmacologyPharmaceutical Nanotechnology	2009	940
PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat V. Bhardwaj, D. D. Ankola, Shantanu Gupta, Pharmaceutical Research NanoparticlesNanomedicineEngineeringChemical-induced Breast CancerPolymer-drug Conjugate	2009	143
Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? D. D. Ankola, Bhoomi Viswanad, V. Bhardwaj, European Journal of Pharmaceutics and Biopharmaceutics NanomedicineHypertensionCoenzyme Q10Antihypertensive TherapyPharmacology	2007	110
Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives Charitra N. Grama, D. D. Ankola, M. N. V. Ravi Kumar Current Opinion in Colloid & Interface Science Nano-drug DeliveryPeroral DeliveryDrug Delivery System	2010	43
Nanoparticles Enhance <I>Per Oral</I> Bioavailability of Poorly Available Molecules: Epigallocatechin Gallate Nanoparticles Ameliorates Cyclosporine Induced Nephrotoxicity in Rats at Three Times Lower Dose Than Oral Solution J. L. Italia, P.K. Datta, D. D. Ankola, Journal of Biomedical Nanotechnology NanoparticlesPharmaceutical ScienceNanotherapeuticsEngineeringNanotoxicology	2008	40
Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure<sup>®</sup> in Treating Hyperlipidemia Asha Meena, D. Venkat Ratnam, D. D. Ankola, Lipids NanoparticlesNanotherapeuticsEngineeringHyperlipidemiaTreating Hyperlipidemia	2008	38
Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A D. D. Ankola, Antonella Battisti, Roberto Solaro, Journal of The Royal Society Interface	2010	22
Multiblock Copolymers of Lactic Acid and Ethylene Glycol Containing Periodic Side-Chain Carboxyl Groups: Synthesis, Characterization, and Nanoparticle Preparation D. D. Ankola, M. N. V. Ravi Kumar, Roberto Solaro Macromolecules Macromolecular ChemistryEngineeringPolymer ChainChemistryPolymers	2009	17
Nanoparticulate Delivery Can Improve <I>Peroral</I> Bioavailability of Cyclosporine and Match Neoral C<SUB>max</SUB> Sparing the Kidney from Damage D. D. Ankola, R. M. Wadsworth, M. N. V. Ravi Kumar Journal of Biomedical Nanotechnology NanotherapeuticsEngineeringImmunologyBiomedical EngineeringImmunotherapy	2011	16
Preparation, characterization and<i>in silico</i>modeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10 D. D. Ankola, Ernest W. Durbin, Gavin A. Buxton, Nanotechnology NanoparticlesEngineeringNanoporous MaterialCoenzyme Q10Bio-based Nanomaterials	2010	13

Page 1